Cerus’ flow diverter aneurism device receives CE markMay 9, 2020
Cerus Endovascular Ltd announced that it has received CE Mark approval for its Neqstent Coil Assisted Flow Diverter device, to treat intracranial aneurysms.
Neqstent is designed to treat a range of aneurysm morphologies including wide-necked bifurcation and bifurcation aneurysms.
It is an adjunctive intrasaccular flow diverter device that provides stable aneurysm neck coverage for the placement of embolisation coils within the sac and long-term occlusion of the aneurysm.
The devices are constructed from a visible super elastic mesh braid and are delivered and deployed in a similar manner as the Contour Neurovascular System.
Neqstent is sized only to the aneurysm neck and designed for use in combination with embolisation coils. The device maintains the coils inside the aneurysm sac without requiring parent vessel stabilisation.
Commercial sales, via a controlled market release across the European Union (EU), are expected to begin during the fourth quarter of 2020, the company said.